XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenue
Expenses:        
Cost of sales
Research and development 203 18,238 1,819 27,243
Selling, general and administrative 27,621 38,050 63,866 79,450
Total expenses 27,824 56,288 65,685 106,693
Loss from operations (27,824) (56,288) (65,685) (106,693)
Other income (expense)        
Interest income (expense)
Net loss $ (27,824) $ (56,288) $ (65,685) $ (106,693)
Net loss per share - basic and diluted (in dollars per share) $ 0 $ 0 $ 0 $ 0
Weighted-average number of common shares outstanding - basic and diluted (in shares) 45,572,568 45,572,568 45,572,568 45,572,568